Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Utah House approves Cannabidiol Product Act after sponsor frames regulation and DEA-waiver plan
Summary
The House passed the second substitute to the Cannabidiol Product Act, which would require state registration and testing of CBD products and direct Utah to seek a DEA waiver to develop an approved, pharmacy-dispensed CBD medicine; the bill passed 49–20.
The Utah House passed the second substitute to the Cannabidiol Product Act (second substitute, Senate Bill 130) after a floor presentation and questions about enforcement, safety, and the federal waiver process. The bill would require producers who sell cannabidiol (CBD) products in Utah to register with the Department of Agriculture, submit products for testing, and verify that labels match contents; it also directs the state to apply to the U.S. Drug Enforcement Administration for a waiver to permit development and pharmacy dispensing of an approved CBD medicinal product.
House sponsor Representative Doh told colleagues the measure separates two distinct objectives: "The first…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
